FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Patricia Rayman

Research Profile

Disorders

Anatomy

Physiology

Chemicals & Drugs

Concepts & Ideas

T-Lymphocyte Subsets

Procedures

Coculture Techniques

Co-author Network

Publications

TOP 3
Baisakhi Raychaudhuri; Patricia Rayman; Joanna Ireland; Jennifer Ko; Brian Rini; Ernest C Borden; Jorge Garcia; Michael A Vogelbaum; James Finke
Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma.
Jennifer S Ko; Patricia Rayman; Joanna Ireland; Shadi Swaidani; Geqiang Li; Kevin D Bunting; Brian Rini; James H Finke; Peter A Cohen
Direct and differential suppression of myeloid-derived suppressor cell subsets by sunitinib is compartmentally constrained.
Grace X Zhou; Joanna Ireland; Patricia Rayman; James Finke; Ming Zhou
Quantification of carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked immunosorbent assay: prognostic and diagnostic potentials.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Patricia Rayman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Baisakhi Raychaudhuri; Patricia Rayman; Joanna Ireland; Jennifer Ko; Brian Rini; Ernest C Borden; Jorge Garcia; Michael A Vogelbaum; James Finke
Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma.
Neuro-oncology 2011;13(6):591-9.
2010: Jennifer S Ko; Patricia Rayman; Joanna Ireland; Shadi Swaidani; Geqiang Li; Kevin D Bunting; Brian Rini; James H Finke; Peter A Cohen
Direct and differential suppression of myeloid-derived suppressor cell subsets by sunitinib is compartmentally constrained.
Cancer research 2010;70(9):3526-36.
2010: Grace X Zhou; Joanna Ireland; Patricia Rayman; James Finke; Ming Zhou
Quantification of carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked immunosorbent assay: prognostic and diagnostic potentials.
Urology 2010;75(2):257-61.
2009: Soumika Biswas; Kaushik Biswas; Amy Richmond; Jennifer Ko; Sankar Ghosh; Matthew Simmons; Patricia Rayman; Brian Rini; Inderbir Gill; Charles S Tannenbaum; James H Finke
Elevated levels of select gangliosides in T cells from renal cell carcinoma patients is associated with T cell dysfunction.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(8):5050-8.
2009: Gaurisankar Sa; Tanya Das; Christina Moon; Cynthia M Hilston; Patricia Rayman; Brian I Rini; Charles S Tannenbaum; James H Finke
GD3, an overexpressed tumor-derived ganglioside, mediates the apoptosis of activated but not resting T cells.
Cancer research 2009;69(7):3095-104.
2009: Jennifer S Ko; Arnold H Zea; Brian I Rini; Joanna L Ireland; Paul Elson; Peter Cohen; Ali-Reza Golshayan; Patricia Rayman; Laura Wood; Jorge Garcia; Robert Dreicer; Ronald Bukowski; James H Finke
Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(6):2148-57.
2008: James H Finke; Brian I Rini; Joanna Ireland; Patricia Rayman; Amy Richmond; Ali-Reza Golshayan; Laura Wood; Paul Elson; Jorge Garcia; Robert Dreicer; Ronald Bukowski
Sunitinib reverses type-1 immune suppression and decreases T-regulatory cells in renal cell carcinoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(20):6674-82.
2008: Maryam Zamanian-Daryoush; Joao T Marques; Michael Gantier; Mark A Behlke; Matthias John; Patricia Rayman; James Finke; Bryan R G Williams
Determinants of cytokine induction by small interfering RNA in human peripheral blood mononuclear cells.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2008;28(4):221-33.
2008: Tanya Das; Gaurisankar Sa; Ewa Paszkiewicz-Kozik; Cynthia Hilston; Luis Molto; Patricia Rayman; Daisuke Kudo; Kaushik Biswas; Ronald M Bukowski; James H Finke; Charles S Tannenbaum
Renal cell carcinoma tumors induce T cell apoptosis through receptor-dependent and receptor-independent pathways.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(7):4687-96.
2007: gira Raval; Soumika Biswas; Patricia Rayman; Kaushik Biswas; Gaurisankar Sa; Sankar Ghosh; Mark Thornton; Cynthia Hilston; Tanya Das; Ronald Bukowski; James Finke; Charles S Tannenbaum
TNF-alpha induction of GM2 expression on renal cell carcinomas promotes T cell dysfunction.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(10):6642-52.
2006: Kaushik Biswas; Amy L Richmond; Patricia Rayman; Soumika Biswas; Mark Thornton; Gaurisankar Sa; Tanya Das; Renliang Zhang; ali chahlavi; Charles S Tannenbaum; Andrew C Novick; Ronald Bukowski; James H Finke
GM2 expression in renal cell carcinoma: potential role in tumor-induced T-cell dysfunction.
Cancer research 2006;66(13):6816-25.
2005: ali chahlavi; Patricia Rayman; Amy L Richmond; Kaushik Biswas; Renliang Zhang; Michael A Vogelbaum; Charles S Tannenbaum; Gene Barnett; James H Finke
Glioblastomas induce T-lymphocyte death by two distinct pathways involving gangliosides and CD70.
Cancer research 2005;65(12):5428-38.
2004: Patricia Rayman; Amy Wesa; Amy L Richmond; Tanya Das; Kaushik Biswas; gira Raval; Walter J Storkus; Charles S Tannenbaum; Andrew C Novick; Ronald Bukowski; James Finke
Effect of renal cell carcinomas on the development of type 1 T-cell responses.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(18 Pt 2):6360S-6S.
2004: James H Finke; Charles S Tannenbaum; Walter J Storkus; Patricia Rayman; Tanya Das; Kaushik Biswas; Amy L Richmond; C Moon; Mark Thornton; I Gill; Andrew C Novick; Ronald Bukowski
Tumor-induced dysfunction in T lymphocytes: increased sensitivity to apoptosis.
Der Urologe. Ausg. A 2004;43 Suppl 3():S131-2.
2004: Mark V Thornton; Daisuke Kudo; Patricia Rayman; Claudine Horton; Luis Molto; Martha K Cathcart; Christopher Ng; Ewa Paszkiewicz-Kozik; Ronald Bukowski; Ithaar H Derweesh; Charles S Tannenbaum; James H Finke
Degradation of NF-kappa B in T cells by gangliosides expressed on renal cell carcinomas.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(6):3480-90.
2003: Luis Molto; Patricia Rayman; Ewa Paszkiewicz-Kozik; Mark Thornton; Lisa Reese; John C Thomas; Tanya Das; Daisuke Kudo; Ronald Bukowski; James Finke; Charles S Tannenbaum
The Bcl-2 transgene protects T cells from renal cell carcinoma-mediated apoptosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(11):4060-8.
2003: Daisuke Kudo; Patricia Rayman; Claudine Horton; Martha K Cathcart; Ronald M Bukowski; Mark Thornton; Charles S Tannenbaum; James H Finke
Gangliosides expressed by the renal cell carcinoma cell line SK-RC-45 are involved in tumor-induced apoptosis of T cells.
Cancer research 2003;63(7):1676-83.
2003: Ithaar H Derweesh; Charles S Tannenbaum; Patricia Rayman; James H Finke
Mechanisms of immune dysfunction in renal cell carcinoma.
Cancer treatment and research 2003;116():29-51.
2001: M A Hussein; Kate Wakeling; Paul Elson; James Finke; D McLain; Patricia Rayman; L A Rybicki; R A Bukowski
GM-CSF safety and effects in the management of advanced/refractory multiple myeloma patients: a phase I trial.
Journal of cancer research and clinical oncology 2001;127(10):619-24.
2001: James H Finke; Patricia Rayman; R George; Charles S Tannenbaum; Vladimir Kolenko; Robert G Uzzo; Andrew C Novick; Ronald M Bukowski
Tumor-induced sensitivity to apoptosis in T cells from patients with renal cell carcinoma: role of nuclear factor-kappaB suppression.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(3 Suppl):940s-946s.
2000: Patricia Rayman; Robert G Uzzo; Vladimir Kolenko; T Bloom; Martha K Cathcart; Luis Molto; Andrew C Novick; Ronald M Bukowski; T Hamilton; James H Finke
Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.
The cancer journal from Scientific American 2000;6 Suppl 1():S81-7.
1999: Ronald M Bukowski; Patricia Rayman; Luis Molto; Charles S Tannenbaum; Thomas Olencki; David M Peereboom; Raymond Tubbs; D McLain; G Thomas Budd; T Griffin; Andrew C Novick; Thomas Hamilton; James Finke
Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10):2780-9.
1999: Robert G Uzzo; Patricia Rayman; Vladimir Kolenko; PE Clark; Martha K Cathcart; T Bloom; Andrew C Novick; Ronald M Bukowski; T Hamilton; James H Finke
Renal cell carcinoma-derived gangliosides suppress nuclear factor-kappaB activation in T cells.
The Journal of clinical investigation 1999;104(6):769-76.
1999: Vladimir Kolenko; T Bloom; Patricia Rayman; Ronald Bukowski; Eric D Hsi; James Finke
Inhibition of NF-kappa B activity in human T lymphocytes induces caspase-dependent apoptosis without detectable activation of caspase-1 and -3.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(2):590-8.
1999: Robert G Uzzo; Patricia Rayman; Vladimir Kolenko; PE Clark; T Bloom; AM Ward; Luis Molto; Charles S Tannenbaum; L J Worford; Ronald Bukowski; Raymond Tubbs; Eric D Hsi; NH Bander; Andrew C Novick; James H Finke
Mechanisms of apoptosis in T cells from patients with renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(5):1219-29.
1999: Robert G Uzzo; PE Clark; Patricia Rayman; T Bloom; Lisa Rybicki; Andrew C Novick; Ronald M Bukowski; James H Finke
Alterations in NFkappaB activation in T lymphocytes of patients with renal cell carcinoma.
Journal of the National Cancer Institute 1999;91(8):718-21.
1999: Vladimir Kolenko; Patricia Rayman; B Roy; Martha K Cathcart; John O'Shea; Raymond Tubbs; Lisa Rybicki; Ronald Bukowski; James Finke
Downregulation of JAK3 protein levels in T lymphocytes by prostaglandin E2 and other cyclic adenosine monophosphate-elevating agents: impact on interleukin-2 receptor signaling pathway.
Blood 1999;93(7):2308-18.
1999: James Ulchaker; J Panuto; Patricia Rayman; Andrew C Novick; Paul Elson; Raymond Tubbs; James H Finke; Ronald M Bukowski
Interferon-gamma production by T lymphocytes from renal cell carcinoma patients: evidence of impaired secretion in response to interleukin-12.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1999;22(1):71-9.
1998: Ronald M Bukowski; Patricia Rayman; Robert G Uzzo; T Bloom; Kate Wakeling; David M Peereboom; Thomas Olencki; G Thomas Budd; D McLain; Paul Elson; Andrew C Novick; James H Finke
Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(10):2337-47.
1998: W Ling; Patricia Rayman; Robert G Uzzo; P Clark; H J Kim; Raymond Tubbs; Andrew C Novick; Ronald Bukowski; T Hamilton; James Finke
Impaired activation of NFkappaB in T cells from a subset of renal cell carcinoma patients is mediated by inhibition of phosphorylation and degradation of the inhibitor, IkappaBalpha.
Blood 1998;92(4):1334-41.
1997: S Kudoh; C Redovan; Patricia Rayman; MG Edinger; R R Tubbs; Andrew C Novick; James H Finke; Ronald M Bukowski
Defective granzyme B gene expression and lytic response in T lymphocytes infiltrating human renal cell carcinoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1997;20(6):479-87.
1997: Vladimir Kolenko; Q Wang; M C Riedy; John O'Shea; Jerome Ritz; Martha K Cathcart; Patricia Rayman; Raymond Tubbs; MG Edinger; Andrew C Novick; Ronald Bukowski; James Finke
Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(6):3057-67.
1997: Ronald M Bukowski; Thomas Olencki; Q Wang; David M Peereboom; G Thomas Budd; Paul Elson; Kate Wakeling; L Tuason; Patricia Rayman; Raymond Tubbs; D McLain; E Klein; Andrew C Novick; James Finke
Phase II trial of interleukin-2 and interferon-alpha in patients with renal cell carcinoma: clinical results and immunologic correlates of response.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1997;20(4):301-11.
1996: Ronald M Bukowski; Thomas Olencki; H Gunn; D McLain; G Thomas Budd; Kate Wakeling; L Tuason; C Redovan; Patricia Rayman; Raymond Tubbs; D Resta; Paul Elson; James Finke
Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findings.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(2):347-57.
1995: S Kudoh; Q Wang; O F Hidalgo; Patricia Rayman; Raymond R Tubbs; M G Edinger; Vladimir Kolenko; J Panuto; Ronald Bukowski; James H Finke
Responses to T cell receptor/CD3 and interleukin-2 receptor stimulation are altered in T cells from B cell non-Hodgkin's lymphomas.
Cancer immunology, immunotherapy : CII 1995;41(3):175-84.
1994: X Li; James Liu; J K Park; Thomas Hamilton; Patricia Rayman; E Klein; M Edinger; Raymond Tubbs; Ronald Bukowski; James Finke
T cells from renal cell carcinoma patients exhibit an abnormal pattern of kappa B-specific DNA-binding activity: a preliminary report.
Cancer research 1994;54(20):5424-9.
1994: James H Finke; Patricia Rayman; L Hart; J Preston Alexander; M G Edinger; Raymond R Tubbs; E Klein; L Tuason; Ronald M Bukowski
Characterization of tumor-infiltrating lymphocyte subsets from human renal cell carcinoma: specific reactivity defined by cytotoxicity, interferon-gamma secretion, and proliferation.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1994;15(2):91-104.
1993: D Sica; Patricia Rayman; J Stanley; M Edinger; Raymond R Tubbs; E Klein; Ronald Bukowski; James H Finke
Interleukin 7 enhances the proliferation and effector function of tumor-infiltrating lymphocytes from renal-cell carcinoma.
International journal of cancer. Journal international du cancer 1993;53(6):941-7.
1992: James H Finke; Patricia Rayman; M Edinger; Raymond R Tubbs; J Stanley; E Klein; Ronald Bukowski
Characterization of a human renal cell carcinoma specific cytotoxic CD8+ T cell line.
Journal of immunotherapy : official journal of the Society for Biological Therapy 1992;11(1):1-11.
1991: Ronald M Bukowski; WILLIAM SHARFMAN; S Murthy; Patricia Rayman; Raymond Tubbs; J Alexander; G Thomas Budd; J S Sergi; L Bauer; V Gibson
Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinoma.
Cancer research 1991;51(16):4199-205.
1990: James H Finke; Patricia Rayman; J Alexander; M Edinger; Raymond R Tubbs; R Connelly; Edson J Pontes; Ronald Bukowski
Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.
Cancer research 1990;50(8):2363-70.
1990: J Alexander; Patricia Rayman; M Edinger; R Connelly; Raymond Tubbs; Ronald Bukowski; Edson J Pontes; James Finke
TIL from renal-cell carcinoma: restimulation with tumor influences proliferation and cytolytic activity.
International journal of cancer. Journal international du cancer 1990;45(1):119-24.